跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROBITUSSIN COMPLETE DAYTIME - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ROBITUSSIN COMPLETE DAYTIME
Authorized
STANDARD
ROBITUSSIN COMPLETE DAYTIME
pfizer consumer healthcare a division of pfizer canada ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
28a138422ef6f4b8
Company
pfizer consumer healthcare a division of pfizer canada ulc
Type
Standard
Approval Details
Approval Id
28a138422ef6f4b8
Drug Approval Canada Name
ROBITUSSIN COMPLETE DAYTIME
Product Name
ROBITUSSIN COMPLETE DAYTIME
Status
Cancelled Post Market
Status Date
2019-08-31
Original Market Date
2017-09-15
Din
02449196
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
OTC
Ahfs
48:08.00
Atc Original
N02BE51 ACETAMINOPHEN, COMB EXCL PSYCHOLEPTICS
Atc Name
n 02 be 51
Aig Number
0351264003
Company Name
pfizer consumer healthcare a division of pfizer canada ulc
Company Address
55 Standish Court, Suite 450, Mississauga, Ontario, Canada, L5R 4B2
Active Ingredients
ACETAMINOPHEN
325 MG
DEXTROMETHORPHAN HYDROBROMIDE
10 MG
PHENYLEPHRINE HYDROCHLORIDE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
28a138422ef6f4b8
Type
Standard
Back to Health Canada Approvals